← Russell 3000 cross-section

USNA USANA HEALTH SCIENCES INC

Trailing twelve months to 2026-07-04 · as filed 2026-08-13, not restated
Healthcare

Scale

Market cap
$253m
Revenue TTM
$913m
Net income TTM
$-22m
Free cash flow
$16m
Composite score
73.0
Sector rank
#2763

Valuation

P / E
EV / EBITDA
2.7
EV / sales
0.1
FCF yield
6.30%
Earnings yield vs 10-yr
-13.51pp

Earnings yield vs 10-yr compares what the business earns per pound invested against the 4.73% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.

Quality and growth

Net margin
-2.4%
EBITDA margin
3.4%
ROE
-4.2%
ROIC
-0.3%
Revenue growth
1.6%

Insider activity, last 90 days

Net open-market
$-0.29m
Buyers
0
Sellers
3

Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.

What management said

Core Nutritional: Core Nutritional is our primary business with approximately 84% of consolidated net sales during the six months ended July 4, 2026. During the six months ended July 4, 2026, net sales outside of the United States represented 91.1% of Core Nutritional net sales. Rise's revenue is generated primarily from sales to large national retailers and club retailers. The following table summarizes the approximate percentage of total product revenue for our Hiya segment that has been contributed by major product lines for the current and prior-year periods, as indicated: The following table summarizes the approximate percentage of total product revenue for our Rise segment that has bee …USANA HEALTH SCIENCES INC, 10-Q, period ended 2026-07-04, filed 2026-08-13

Read the full passage →